Skip to content

Immunotherapy and Targeted Therapy

Immunotherapy & Targeted Therapy






Immunotherapy and Targeted Therapy Cancer Hospital in Banjara Hills, Hyderabad

Immunotherapy and targeted therapy are different from chemotherapy

When used appropriately, immunotherapy and targeted therapy represent one of the most significant advances in modern cancer treatment.

They are designed to:

Act on specific cancer pathways
Use the body’s immune system to fight cancer
Reduce damage to normal healthy cells
Offer options in advanced or resistant cancers

Targeted Therapy

What Is Targeted Therapy?

Cancer cells often grow because of specific genetic mutations or abnormal proteins. Targeted therapy blocks these precise signals.
It works only when the tumor has the relevant molecular marker.

How Do We Decide?

  • Tumor stageBiomarker testing ( PD L1,MSI-H,dMMR)
  • Tumor type and patient eligibility
  • Tumor stage

Types of Targeted Therapy

When Is Targeted Therapy Used?

Lung cancer with driver mutations
HER2-positive breast cancer
Certain colorectal cancers
Ovarian cancers with BRCA mutations
Gastrointestinal stromal tumors
Select advanced malignancies

Immunotherapy

What Is Immunotherapy?

Your immune system can recognize abnormal cells — but cancer sometimes hides from it.
Immunotherapy removes this “mask” and reactivates immune attack.
It does not directly kill cancer cells.
It empowers your own immune system to do so.

Types of Immunotherapy

Where Immunotherapy Is Commonly Used

Lung cancer
Melanoma
Kidney cancer
Bladder cancer
Head & neck cancers
Certain MSI-high gastrointestinal cancers
Liver cancer
Cervical cancer
Blood cancers

Why These Treatments Require Expertise

These therapies are:

Expensive
Biologically complex
Not suitable for every cancer
Associated with unique side effects

Immune-related side effects can occur  and need structured monitoring

These are different from chemotherapy side effects and require early recognition.

We emphasize:

Careful patient selection
Evidence-based indication
Structured monitoring
Timely side-effect management
Clear patient education

How We Approach Advanced Therapies

Confirm diagnosis and stage
Perform required molecular testing
Evaluate patient fitness and goals
Discuss cost-benefit transparently
Monitor response with imaging and markers
Track immune-related toxicity carefully

FAQ’s

Reviewed By

Medically Reviewed by : Dr. Srinivas Prasad, MCh (Surgical Oncology)
20+ years of experience in oncologic surgery and multidisciplinary cancer care.
Registration No: 2111
Last reviewed: February 2026

Call Now Button